Pharmaniaga Bhd
KLSE:PHARMA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Pharmaniaga Bhd
Cash & Cash Equivalents
Pharmaniaga Bhd
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
P
|
Pharmaniaga Bhd
KLSE:PHARMA
|
Cash & Cash Equivalents
258.6m
|
CAGR 3-Years
70%
|
CAGR 5-Years
45%
|
CAGR 10-Years
28%
|
|
|
Agape ATP Corp
NASDAQ:ATPC
|
Cash & Cash Equivalents
$140.1k
|
CAGR 3-Years
-54%
|
CAGR 5-Years
-48%
|
CAGR 10-Years
N/A
|
|
|
U
|
UMediC Group Bhd
KLSE:UMC
|
Cash & Cash Equivalents
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Pharmaniaga Bhd
Glance View
Pharmaniaga Bhd.operates as an investment holding company. The company is headquartered in Shah Alam, Selangor. The firm is principally engaged in the research and development, manufacturing of generic drugs and medical devices, logistics and distribution, sales, and marketing, as well as community pharmacy. The Company’s segment includes Logistics and distribution, Manufacturing, and Indonesia. The Logistics and distribution segment is engaged in the distribution, trading, and wholesaling of pharmaceutical and medical products as well as supply and installation of medical and hospital equipment in Malaysia. The Manufacturing segment is involved in manufacturing of pharmaceutical products in Malaysia. The Indonesia segment is engaged manufacturing and distribution of pharmaceutical and medical products in Indonesia. Its subsidiaries include Idaman Pharma Manufacturing Sdn. Bhd., Pharmaniaga Manufacturing Berhad, Pharmaniaga LifeScience Sdn. Bhd., Pharmaniaga Logistics Sdn. Bhd., and Pharmaniaga Marketing Sdn. Bhd.
See Also
What is Pharmaniaga Bhd's Cash & Cash Equivalents?
Cash & Cash Equivalents
258.6m
MYR
Based on the financial report for Dec 31, 2025, Pharmaniaga Bhd's Cash & Cash Equivalents amounts to 258.6m MYR.
What is Pharmaniaga Bhd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
28%
Over the last year, the Cash & Cash Equivalents growth was 70%. The average annual Cash & Cash Equivalents growth rates for Pharmaniaga Bhd have been 70% over the past three years , 45% over the past five years , and 28% over the past ten years .
